Efficacy of the edge-to-edge repair in the setting of a dilated ventricle: an in vitro study.

Ann Thorac Surg

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332-0535, USA.

Published: November 2007

Background: The edge-to-edge repair to correct mitral regurgitation (MR) has shown substandard results in cases of ischemic MR or dilated cardiomyopathy.

Methods: Ten porcine mitral valves were investigated in a left heart simulator (120 mm Hg, 5 L/min). Pathologic conditions of a dilated ventricle were simulated by using an annular model capable of three levels of dilation (normal, 56%, and 120%) and by displacing papillary muscles (PMs) 10 mm in the apical, lateral, and posterior directions. The edge-to-edge repair was performed; a central stitch was investigated for symmetric and asymmetric PM displacements, and a paracommissural stitch was investigated for asymmetric PM displacements. Left ventricular pressure and mitral flow rate were monitored, and regurgitation fraction was calculated from the mitral flow curve.

Results: Under symmetric PM displacement, the repair reduced MR by 5.1% at dilation level one and by 9.1% at dilation level two. The repair decreased MR by 10.9% (dilation level two) after asymmetric displacement of the anterior-lateral PM, and by 5.4% (dilation level one) and 7.9% (dilation level two) after asymmetric displacement of the posterior-medial PM. The edge-to-edge repair reduced (p < 0.05) MR owing to annular dilation; however, it was unable to completely eliminate the MR. The repair did not significantly reduce MR caused by PM displacement, regardless of the displacement geometry. Stitch location did not affect repair efficacy.

Conclusions: The edge-to-edge repair is not an effective procedure in correcting MR associated with PM displacement, although it is able to partially reduce MR caused by annular dilation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2007.05.086DOI Listing

Publication Analysis

Top Keywords

edge-to-edge repair
20
dilation level
20
repair
9
dilated ventricle
8
dilation
8
stitch investigated
8
asymmetric displacements
8
mitral flow
8
repair reduced
8
level asymmetric
8

Similar Publications

Functional mitral regurgitation (MR) is associated with increased cardiovascular morbidity and mortality and over the past decade, the diagnosis of atrial functional mitral regurgitation (aFMR) has been increasingly observed in the elderly, especially in those with atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF). Annular enlargement, perturbations of annular contraction, and atriogenic leaflet tethering distinguish the pathophysiology of aFMR from the one of ventricular origin. However, no consensus provides recommendations regarding the differential diagnosis and the subsequent management of aFMR.

View Article and Find Full Text PDF

Background: Transcatheter edge-to-edge repair of the mitral valve (mTEER) reduced a hierarchical end point that included death and heart failure hospitalization in COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation Trial). However, the magnitude to which mTEER increases the number of days a patient spends at home (DAH) in the first few years after treatment, a patient-centered end point not captured routinely in clinical trials, has not been evaluated. We compared 1- and 2-year DAH among patients with functional mitral regurgitation and heart failure randomized to mTEER plus medical therapy versus medical therapy alone (control) by linking the COAPT trial to comprehensive health care claims data.

View Article and Find Full Text PDF

Background: Mitral valve transcatheter edge-to-edge repair (M-TEER) was initially indicated for central degenerative mitral regurgitation (DMR) lesions, but advancements in technology have enabled successful treatment in an increasing number of noncentral DMR patients.

Aims: This study aims to compare procedural outcomes and prognosis between noncentral DMR patients, outside clinical trial anatomical criteria, and central DMR patients undergoing M-TEER.

Methods: Drug-refractory moderate-to-severe DMR patients treated with M-TEER at Fuwai Hospital from January 2021 to February 2024 were retrospectively analyzed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!